PLASMA LIPOPROTEIN(A) CONCENTRATION AND PHENOTYPES IN DIABETES-MELLITUS

被引:85
作者
CSASZAR, A
DIEPLINGER, H
SANDHOLZER, C
KARADI, I
JUHASZ, E
DREXEL, H
HALMOS, T
ROMICS, L
PATSCH, JR
UTERMANN, G
机构
[1] UNIV INNSBRUCK, INST MED BIOL & HUMAN GENET, SCHOEPFSTR 41, A-6020 INNSBRUCK, AUSTRIA
[2] SEMMELWEIS UNIV MED, DEPT MED 3, H-1085 BUDAPEST 8, HUNGARY
[3] KORANYL INST, DEPT MED, BUDAPEST, HUNGARY
关键词
DIABETES-MELLITUS; LIPOPROTEIN(A); APO(A) ISOFORMS;
D O I
10.1007/BF00399092
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus are at increased risk of developing atherosclerotic vascular diseases. A variety of lipoprotein abnormalities have been described as being associated with this increased risk. In this study, apo(a) isoform frequencies and lipoprotein(a) [Lp(a)] concentrations were determined in Type 1 and Type 2 diabetic patients in order to investigate a possible contribution of Lp(a) to the increased risk for atherosclerosis in diabetes. No significant differences in plasma Lp(a) concentrations were found in two ethnically different populations (Austrians from the province of Tyrol and Hungarians from Budapest) in either type of diabetes when compared to respective control groups (91 Type 1 and 112 Type 2 diabetic patients vs 202 control subjects in the Hungarian study and 44 Type 1 diabetic and 44 Type 2 diabetic vs 125 control subjects in the Austrian study). There were also no significant apo(a) isoform frequency differences between both patient groups and control subjects in the two study groups. These data, obtained from two large ethnically different populations, provide no evidence of a contribution of Lp(a) to the increased risk for atherosclerosis in diabetes.
引用
收藏
页码:47 / 51
页数:5
相关论文
共 41 条
[1]   IMMUNOCHEMICAL QUANTIFICATION OF HUMAN PLASMA LP(A) LIPOPROTEIN [J].
ALBERS, JJ ;
HAZZARD, WR .
LIPIDS, 1974, 9 (01) :15-26
[2]   INTERACTION OF LIPOPROTEIN LP(A) AND LOW-DENSITY LIPOPROTEIN WITH GLYCOSAMINOGLYCANS FROM HUMAN AORTA [J].
BIHARIVARGA, M ;
GRUBER, E ;
ROTHENEDER, M ;
ZECHNER, R ;
KOSTNER, GM .
ARTERIOSCLEROSIS, 1988, 8 (06) :851-857
[3]   INCREASED SERUM LEVELS OF LIPOPROTEIN(A) IN DIABETES-MELLITUS AND THEIR REDUCTION WITH GLYCEMIC CONTROL [J].
BRUCKERT, E ;
DAVIDOFF, P ;
GRIMALDI, A ;
TRUFFERT, J ;
GIRAL, P ;
DOUMITH, R ;
THERVET, F ;
DEGENNES, JL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (01) :35-36
[4]   LIPOPROTEIN(A) INHIBITION OF PLASMINOGEN ACTIVATION BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].
EDELBERG, JM ;
GONZALEZGRONOW, M ;
PIZZO, SV .
THROMBOSIS RESEARCH, 1990, 57 (01) :155-162
[5]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[6]   PATHOGENESIS OF MACROVASCULAR DISEASE IN THE HUMAN DIABETIC [J].
GANDA, OP .
DIABETES, 1980, 29 (11) :931-942
[7]   MORBIDITY AND MORTALITY IN DIABETICS IN FRAMINGHAM POPULATION - 16-YEAR FOLLOW-UP STUDY [J].
GARCIA, MJ ;
MCNAMARA, PM ;
GORDON, T ;
KANNELL, WB .
DIABETES, 1974, 23 (02) :105-111
[8]  
GAUBATZ JW, 1983, J BIOL CHEM, V258, P4582
[9]   PLASMA LP(A) CONCENTRATION IS INVERSELY CORRELATED WITH THE RATIO OF KRINGLE-IV KRINGLE-V ENCODING DOMAINS IN THE APO(A) GENE [J].
GAVISH, D ;
AZROLAN, N ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :2021-2027
[10]   LACK OF CHANGE OF LIPOPROTEIN (A) CONCENTRATION WITH IMPROVED GLYCEMIC CONTROL IN SUBJECTS WITH TYPE-II DIABETES [J].
HAFFNER, SM ;
TUTTLE, KR ;
RAINWATER, DL .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (02) :116-120